BRAF and Miyoshi myopathy: This case report highlights (1) the benefits that can be obtained with a BRAF inhibitor in real-world patients with MM harboring the BRAFV600R mutation, and (2) the potential application of emerging new techniques such as ctDNA detection in our everyday clinical practice.